Bafna Pharmaceuticals has informed that the board of directors of the company, at its meeting held on 8th day of August, 2017 has considered and approved the Directors report; fixed date, place, and time of 22nd AGM; fixed Book Closure for 22nd AGM; fixed Cut-off Date for voting; to recommend the appointment of Statutory Auditor of the Company; to recommend the re-appointment of Managing Director of the Company; and to recommend the re-appoint of Whole time Director of the Company.
The above information is a part of company’s filings submitted to BSE.
